Acase of hypereosinophilic syndrome presenting with multiorgan infarctions associated with disseminated intravascular coagulation

Allergy, Asthma and Immunology Research

Volumn 4, Issue 3, 2012, Pages 161-164

  Park, Sun Mi ^a   Park, Ji Won ^a   Kim, Sung Min ^a   Koo, Eun Hee ^a   Lee, Jin Young ^a   Lee, Chul Su ^a   Choi, Dong Chull ^a   Lee, Byung Jae ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Consumptive coagulopathy; Disseminated intravascular coagulation; Eosinophilia; Hypereosinophilic syndrome; Interferon alpha; Thromboembolism

Indexed keywords

ALPHA INTERFERON; D DIMER; HEPARIN; METHYLPREDNISOLONE;

ABDOMINAL PAIN; ABDOMINAL RADIOGRAPHY; ADULT; ANTICOAGULANT THERAPY; ARTICLE; BRAIN HEMORRHAGE; BRAIN SCINTISCANNING; CASE REPORT; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; FEVER; FLANK PAIN; HEADACHE; HEMOPTYSIS; HUMAN; HYPEREOSINOPHILIC SYNDROME; LEG THROMBOSIS; LEUKOCYTE COUNT; LUNG EMBOLISM; LUNG INFARCTION; PROTHROMBIN TIME; SPLEEN INFARCTION; THORAX RADIOGRAPHY; THROMBOCYTOPENIA;

EID: 84861789876     PISSN: 20927355     EISSN: 20927363     Source Type: Journal    
DOI: 10.4168/aair.2012.4.3.161     Document Type: Article

References (20)

1. Klion A. Hypereosinophilic syndrome: current approach to diagnosis and treatment. Annu Rev Med 2009;60:293-306.
2. Ogbogu PU, Rosing DR, Horne MK 3rd. Cardiovascular manifestations of hypereosinophilic syndromes. Immunol Allergy Clin North Am 2007;27:457-75.
3. Yeung TF, Lau SW, Wong K. An unusual case of hypereosinophilic syndrome and disseminated intravascular coagulation. Chin Med J (Engl) 2005;118:1582-4.
4. Miyagi J, Ichimiya M, Ozaki K, Goto T, Fujino O, Nagata J, Hiasa Y. Hypereosinophilic syndrome complicated by disseminated intravascular coagulation (DIC), deep venous thrombosis and pulmonary embolism. Nihon Naika Gakkai Zasshi 2004;93:364-6.
5. Nagashima M, Nishizawa M, Yamauchi T, Mori S, Honma Y. A case of the idiopathic hypereosinophilic syndrome presenting with mononeuritis multiplex, multiple thrombosis, and disseminated intravascular coagulation. Rinsho Shinkeigaku 1986;26:698-703.
6. Fukuta A, Hara T, Tsurumi H, Moriwaki H. Hypereosinophilic syndrome with DIC treated successfully with a combination of high-dose methylprednisolone and cyclosporin A. Rinsho Ketsueki 2001; 42:1145-7.
7. Chusid MJ, Dale DC, West BC, Wolff SM. The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine (Baltimore) 1975;54:1-27.
8. Simon HU, Rothenberg ME, Bochner BS, Weller PF, Wardlaw AJ, Wechsler ME, Rosenwasser LJ, Roufosse F, Gleich GJ, Klion AD. Refining the definition of hypereosinophilic syndrome. J Allergy Clin Immunol 2010;126:45-9.
9. Venge P, Dahl R, Hällgren R. Enhancement of factor XII dependent reactions by eosinophil cationic protein. Thromb Res 1979;14:641-9.
10. Rohrbach MS, Wheatley CL, Slifman NR, Gleich GJ. Activation of platelets by eosinophil granule proteins. J Exp Med 1990;172:1271-4.
11. Slungaard A, Vercellotti GM, Tran T, Gleich GJ, Key NS. Eosinophil cationic granule proteins impair thrombomodulin function. A potential mechanism for thromboembolism in hypereosinophilic heart disease. J Clin Invest 1993;91:1721-30.
12. Mukai HY, Ninomiya H, Ohtani K, Nagasawa T, Abe T. Major basic protein binding to thrombomodulin potentially contributes to the thrombosis in patients with eosinophilia. Br J Haematol 1995;90: 892-9.
13. Wang JG, Mahmud SA, Thompson JA, Geng JG, Key NS, Slungaard A. The principal eosinophil peroxidase product, HOSCN, is a uniquely potent phagocyte oxidant inducer of endothelial cell tissue factor activity: a potential mechanism for thrombosis in eosinophilic inflammatory states. Blood 2006;107:558-65.
14. Park YM, Bochner BS. Eosinophil survival and apoptosis in health and disease. Allergy Asthma Immunol Res 2010;2:87-101.
15. Kobayashi M, Komatsu N, Kuwayama Y, Bandobashi K, Kubota T, Uemura Y, Taguchi H. Idiopathic hypereosinophilic syndrome presenting acute abdomen. Intern Med 2007;46:675-8.
16. Ferguson GT, Starkebaum G. Thromboangiitis obliterans associated with idiopathic hypereosinophilia. Arch Intern Med 1985;145: 1726-8.
17. Ceretelli S, Capochiani E, Petrini M. Interferon-alpha in the idiopathic hypereosinophilic syndrome: consideration of five cases. Ann Hematol 1998;77:161-4.
18. Yamada O, Kitahara K, Imamura K, Ozasa H, Okada M, Mizoguchi H. Clinical and cytogenetic remission induced by interferon-alpha in a patient with chronic eosinophilic leukemia associated with a unique t(3;9;5) translocation. Am J Hematol 1998;58:137-41.
19. Fruehauf S, Fiehn C, Haas R, Doehner H, Hunstein W. Sustained remission of idiopathic hypereosinophilic syndrome following alpha-interferon therapy. Acta Haematol 1993;89:91-3.
20. Terrier B, Piette AM, Kerob D, Cordoliani F, Tancrède E, Hamidou L, Lebbé C, Blétry O, Kahn JE. Superficial venous thrombophlebitis as the initial manifestation of hypereosinophilic syndrome: study of the first 3 cases. Arch Dermatol 2006;142:1606-10.